GlaxoSmithKline commissioned XVIVO to create a mechanism of action animation for Theravance’s new class of antibiotic, Vibativ developed to stop serious MRSA infections in hospital settings. Vibativ works by preventing bacterial ribosomes from making proteins, which replicating bacteria require to effectively build new cell walls. Bacteria will run out of cell wall material in the replication process effectively killing them.

“I just want to thank you again for the wonderful job you did for Zirus in designing our award winning animation on viral replication. If it was just how the animation looked and was received by others, you would be great. But what mattered more was how you became trusted partners with us in helping us create value and spreading our message. You have been invaluable to Zirus and we very much appreciate your contributions, talents and professionalism.”
David G. Perryman, President and CEO, Zirus, Inc.